Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-046940
Filing Date
2024-11-14
Accepted
2024-11-14 16:39:41
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 ny20036484x2_s3.htm S-3 409956
2 EXHIBIT 4.4 ny20036484x2_ex4-4.htm EX-4.4 476715
3 EXHIBIT 5.1 ny20036484x2_ex5-1.htm EX-5.1 34239
4 EXHIBIT 23.1 ny20036484x2_ex23-1.htm EX-23.1 1947
5 EXHIBIT 23.2 ny20036484x2_ex23-2.htm EX-23.2 2410
6 EXHIBIT 99.1 ny20036484x2_ex99-1.htm EX-99.1 64574
7 FILING FEES TABLE ny20036484x2_ex107.htm EX-FILING FEES 73914
8 logo_gyre.jpg GRAPHIC 26811
9 ny20038391x1_ex5-1img001.jpg GRAPHIC 34999
  Complete submission text file 0001140361-24-046940.txt   1150072
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283237 | Film No.: 241463517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)